A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times ...

Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) decreased during the last reporting period, falling from 6.46M to 6.42M. This put 12.34% of the company's publicly available shares short.

Pioneering the "Find, Fight and Follow" approach to disease management, Lantheus Holdings (NASDAQGM:LNTH) develops and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

All relevant comments and Lantheus Holdings Inc share chat regarding the LNTH NASDAQ share news are listed here in the LNTH forum. View and contribute to the LNTH share chat. Discuss Lantheus Holdings ...

Lantheus Holdings, Inc. has a 52 week low of $58.46 and a 52 week high of $126.89. The stock has a market cap of $6.23 billion, a P/E ratio of 15.13 and a beta of 0.38. Want More Great Investing ...

Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our Twin Momentum Investor model based on the published ...

Here's a peek at a few of the choices from the screener. Overview: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling ...